Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brock

Showing results (41-50 of 232) with videos related to

Pageof 24
Sort By:
The Journal of Sexual Medicine|February 18, 2011
The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomesEric Chung, Ling Deyoung, Gerald B Brock
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Clinical aspects and treatment of juvenile Graves' diseaseH Perrild, L Lavard, B Brock-Jacobsen
Current Urology Reports|June 19, 2013
Daily dosing of PDE5 inhibitors: where does it fit in?King Chien Joe Lee, Gerald B Brock
Translational Andrology and Urology|January 28, 2016
Strategies for maintaining penile size following penile implantKing Chien Joe Lee, Gerald B Brock
Nature Reviews. Urology|July 7, 2009
Surgery: centers of excellence for penile prosthesis: yes or no?Tariq F Al-Shaiji, Gerald B Brock
Metabolism: Clinical and Experimental|August 31, 2004
Long-Term exposure of INS-1 cells to cis and trans fatty acids influences insulin release and fatty acid oxidation differentiallyK K Alstrup, B Brock, K Hermansen
Current Pharmaceutical Design|October 29, 2009
Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatmentT F Al-Shaiji, G B Brock
Thescientificworldjournal|September 8, 2009
Peyronie's disease: evolving surgical management and the role of phosphodiesterase 5 inhibitorsTariq F Al-Shaiji, Gerald B Brock
Cancer Research|January 27, 1998
Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3H Huynh, R M Seyam, G B Brock
The Journal of Trauma|July 27, 1999
Erectile dysfunction induced by orthopedic trauma managed with a fracture table: a case report and review of the literatureP T Chan, R Schondorf, G B Brock
Pageof 24

Showing results (41-50 of 232) with videos related to

Sort By:
Pageof 24
The Journal of Sexual Medicine|February 18, 2011
The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomesEric Chung, Ling Deyoung, Gerald B Brock
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Clinical aspects and treatment of juvenile Graves' diseaseH Perrild, L Lavard, B Brock-Jacobsen
Current Urology Reports|June 19, 2013
Daily dosing of PDE5 inhibitors: where does it fit in?King Chien Joe Lee, Gerald B Brock
Translational Andrology and Urology|January 28, 2016
Strategies for maintaining penile size following penile implantKing Chien Joe Lee, Gerald B Brock
Nature Reviews. Urology|July 7, 2009
Surgery: centers of excellence for penile prosthesis: yes or no?Tariq F Al-Shaiji, Gerald B Brock
Metabolism: Clinical and Experimental|August 31, 2004
Long-Term exposure of INS-1 cells to cis and trans fatty acids influences insulin release and fatty acid oxidation differentiallyK K Alstrup, B Brock, K Hermansen
Current Pharmaceutical Design|October 29, 2009
Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatmentT F Al-Shaiji, G B Brock
Thescientificworldjournal|September 8, 2009
Peyronie's disease: evolving surgical management and the role of phosphodiesterase 5 inhibitorsTariq F Al-Shaiji, Gerald B Brock
Cancer Research|January 27, 1998
Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3H Huynh, R M Seyam, G B Brock
The Journal of Trauma|July 27, 1999
Erectile dysfunction induced by orthopedic trauma managed with a fracture table: a case report and review of the literatureP T Chan, R Schondorf, G B Brock
Pageof 24